Literature DB >> 3955523

Idiopathic deep vein thrombosis in an apparently healthy patient as a premonitory sign of occult cancer.

D Aderka, A Brown, A Zelikovski, J Pinkhas.   

Abstract

An association between migratory venous thrombosis or acute pulmonary embolism and occult cancer has been previously suggested. The relationship between the commoner deep venous thrombosis (DVT) in an otherwise healthy individual and occult cancer is not known. The incidence of cancer in 35 otherwise healthy patients with idiopathic DVT (group A) was compared to 48 patients with DVT due to a known etiology, excluding cancer (group B). In 12 patients of group A (34%), a diagnosis of cancer was established 4-68 months after the DVT episode, compared to 2 patients of group B (4%) (P = 0.001). The origin of the earliest discovered cancer (up to 8 months) was the reproductive organs (ovary, endometrium, prostate, breast), while the later discovered malignancies were of colon, pancreas, lung and a lymphoma. At the initial idiopathic DVT episode, patients found subsequently to have cancer, were older than the control group (P less than 0.01), had hemoglobin concentration lower than 12.4 g/dl (P less than 0.02), and had eosinophil counts higher than 3% (P less than 0.01). A score devised from these parameters could identify 83% of the patients with cancer and 91% of those without malignancy (P = 0.00003). These findings indicate that there is a correlation between idiopathic DVT and occult cancer and that the majority of the patients at risk may probably be identified early by the score devised.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3955523     DOI: 10.1002/1097-0142(19860501)57:9<1846::aid-cncr2820570925>3.0.co;2-3

Source DB:  PubMed          Journal:  Cancer        ISSN: 0008-543X            Impact factor:   6.860


  7 in total

Review 1.  Complications of long-term home total parenteral nutrition: their identification, prevention and treatment.

Authors:  A L Buchman
Journal:  Dig Dis Sci       Date:  2001-01       Impact factor: 3.199

2.  Should we look further for cancer in a patient with venous thromboembolism?

Authors:  D E Arterburn; W S Richardson
Journal:  West J Med       Date:  2000-05

3.  Risk Factors and Outcomes of De Novo Cancers (Excluding Nonmelanoma Skin Cancer) After Liver Transplantation for Primary Sclerosing Cholangitis.

Authors:  Mohamad A Mouchli; Siddharth Singh; Edward V Loftus; Lisa Boardman; Jayant Talwalkar; Charles B Rosen; Julie K Heimbach; Russell H Wiesner; Bashar Hasan; John J Poterucha; Watt D Kymberly
Journal:  Transplantation       Date:  2017-08       Impact factor: 4.939

4.  Clinical characteristics of pulmonary embolism with underlying malignancy.

Authors:  Ji Eun Lee; Hye-Ryoun Kim; Sang-Min Lee; Jae-Joon Yim; Chul-Gyu Yoo; Young Whan Kim; Sung Koo Han; Young-Soo Shim; Seok-Chul Yang
Journal:  Korean J Intern Med       Date:  2010-02-26       Impact factor: 2.884

5.  Eosinophilia and first-line coagulation testing.

Authors:  Giuseppe Lippi; Martina Montagnana; Gian Luca Salvagno; Massimo Franchini; Giovanni Targher; Gian Cesare Guidi
Journal:  J Thromb Thrombolysis       Date:  2008-07-10       Impact factor: 2.300

Review 6.  Eosinophils in glioblastoma biology.

Authors:  Colleen S Curran; Paul J Bertics
Journal:  J Neuroinflammation       Date:  2012-01-17       Impact factor: 8.322

Review 7.  Eosinophils from Physiology to Disease: A Comprehensive Review.

Authors:  Giuseppe A Ramirez; Mona-Rita Yacoub; Marco Ripa; Daniele Mannina; Adriana Cariddi; Nicoletta Saporiti; Fabio Ciceri; Antonella Castagna; Giselda Colombo; Lorenzo Dagna
Journal:  Biomed Res Int       Date:  2018-01-28       Impact factor: 3.411

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.